Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Parenteral Nutrition Market

Parenteral Nutrition Market Trends

Report ID: GMI3216
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Parenteral Nutrition Market Trends

The increasing prevalence of metabolic & chronic disorders is anticipated to drive the demand for parenteral nutrition solutions and services across the globe. The significant upsurge in the prevalence rates of non-communicable diseases including obesity, malnutrition, type-2 diabetes, and cardiovascular diseases among others that are known to lead to prolonged hospitalization, and increased mortality rates are expected to prove conducive to the industry development.
These disorders often lead to impaired digestion, absorption, or utilization of essential nutrients, including proteins, carbohydrates, and fats. As a result, patients with metabolic disorders require parenteral nutrition to meet their nutritional needs. As per the World Health Organization (WHO), in 2019, cardiovascular conditions were responsible for 17.9 million deaths, accounting for an estimated 31% of the deaths globally. The management of such chronic diseases is generally multidimensional that comprises several aspects including parenteral nutrition.

Further, the rise in metabolic diseases and related mortality offers immense potential for business growth and opportunity for the market players to establish and penetrate the untapped market. Thus, the growing incidence of metabolic and chronic diseases is expected to expedite the market demand.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Parenteral nutrition industry size was USD 5.7 billion in 2022 and is projected to record USD 11.2 million by 2032 due to the increasing prevalence of chronic diseases and gastrointestinal disorders across the world

The RTU/standard commercial parenteral nutrition industry held 88.3% revenue share in 2022 and is projected to experience 7% CAGR from 2023-2032 driven by immense popularity among healthcare professionals for reducing the need for on-site compounding and ensuring accurate nutrient delivery.

North America garnered 30% of the parenteral nutrition industry share in 2022 and is anticipated to expand at 7.2% CAGR through 2023 owing to the presence of well-established healthcare infrastructure in the region.

B. Braun Melsungen AG, Baxter International, Inc., Fresenius Kabi AG, OTSUKA HOLDINGS CO., LTD, Amanta Healthcare, Grifols International S.A., ICU Medical, Aculife Healthcare, AbbVie, Inc, and Aguettant are some of the major parenteral nutrition industry players.